ZMYND8 expression in plasma cell leukemia (PCL), which is a highly aggressive terminal stage of MM, was lower than that in MM and normal samples (Figure 1B and Figure S1C,D (Supporting Information)). Here, ZMYND8 is linked to Miyoshi myopathy.